Even though the direct relevance of this Stat1−/− mouse model in relation to human infection with JEV needs to be further confirmed, data for in vivo protection of CLEC5A mAbs still shed light on its therapeutic potential for blocking neuroinflammation. This evidence concerns the gene CLEC5A and infection.